To investigate the antidepressant effect of high-dose milnacipran, we retrospectively compared three groups of inpatients with major depression; those who were given milnacipran > __number__ mg/day (high-dose milnacipran group), those treated with milnacipran at maximum doses of __number__ mg/day (standard-dose milnacipran group), and those treated with paroxetine at maximum doses of __number__ mg/day (paroxetine group).